Read + Share
Kitano S, Fujiwara Y, Shimizu T, Iwasa S, et al. A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with
advanced solid tumors. Cancer Chemother Pharmacol 2022;90:523-529.
PMID: 36289094
|
 |
|
Kitano S, Fujiwara Y, Shimizu T, Iwasa S, et al. A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with
advanced solid tumors. Cancer Chemother Pharmacol 2022;90:523-529.
PMID: 36289094
|
|
|
|